A61K 35/761
Adenovirus
A61K35/761 (Adenovirus) appears on 460 US grants and 951 published applications in this corpus.
Search patents in A61K- Granted patents
- 460
- Published applications
- 951
- Assignees
- 404
- Inventors
- 1,471
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 6 | 2 |
| 2002 | 3 | 12 |
| 2003 | 4 | 16 |
| 2004 | 6 | 14 |
| 2005 | 2 | 25 |
| 2006 | 6 | 16 |
| 2007 | 7 | 14 |
| 2008 | 7 | 21 |
| 2009 | 8 | 15 |
| 2010 | 6 | 15 |
| 2011 | 8 | 16 |
| 2012 | 8 | 13 |
| 2013 | 9 | 25 |
| 2014 | 8 | 25 |
| 2015 | 16 | 22 |
| 2016 | 12 | 32 |
| 2017 | 9 | 32 |
| 2018 | 21 | 53 |
| 2019 | 25 | 82 |
| 2020 | 30 | 88 |
| 2021 | 28 | 73 |
| 2022 | 50 | 96 |
| 2023 | 49 | 62 |
| 2024 | 38 | 71 |
| 2025 | 51 | 63 |
| 2026 | 37 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer18 Aug 2026US 12,708,653 B2Endeavor Health Clinical Operations
- Pharmaceutical composition for treating degenerative brain disease, including glycine transporter as active ingredient18 Aug 2026US 12,708,657 B2Amyloid Solution Inc.
- Group B adenovirus-containing formulation28 Jul 2026US 12,691,150 B2Akamis Bio Limited
- Expression cassette coding for vascular endothelial growth factor8 Oct 2026US 2026/0308618 A1Cornell University
- Oncolytic virus therapy1 Oct 2026US 2026/0294987 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Composition and methods for modulation of elovl224 Sep 2026US 2026/0284154 A1The Regents of the University of California
- Methods to treat glioma in subjects with defined tumour microenvironment24 Sep 2026US 2026/0286443 A1University Health Network
- Adenoviral vectors encapsulated in cationic liposomes, and preparation and use thereof10 Sep 2026US 2026/0263363 A1EpicentRx, Inc.
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Method for the production and purification of adenoviral vectors110US 6,194,191 B1Introgen Therapeutics, Inc. · 2001
- Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)108US 6,309,634 B1Avigen, Inc. · 2001
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor91US 8,318,480 B2The Trustees of the University of Pennsylvania · 2012